pIVTRup Citations (7)
Originally described in: pIVTRupUnpublished
Articles Citing pIVTRup
| Articles |
|---|
| An Evolutionarily Conserved Function of Polycomb Silences the MHC Class I Antigen Presentation Pathway and Enables Immune Evasion in Cancer. Burr ML, Sparbier CE, Chan KL, Chan YC, Kersbergen A, Lam EYN, Azidis-Yates E, Vassiliadis D, Bell CC, Gilan O, Jackson S, Tan L, Wong SQ, Hollizeck S, Michalak EM, Siddle HV, McCabe MT, Prinjha RK, Guerra GR, Solomon BJ, Sandhu S, Dawson SJ, Beavis PA, Tothill RW, Cullinane C, Lehner PJ, Sutherland KD, Dawson MA. Cancer Cell. 2019 Oct 14;36(4):385-401.e8. doi: 10.1016/j.ccell.2019.08.008. Epub 2019 Sep 26. PubMed |
| Transgene Expression and Transposition Efficiency of Two-Component Sleeping Beauty Transposon Vector Systems Utilizing Plasmid or mRNA Encoding the Transposase. Tschorn N, van Heuvel Y, Stitz J. Mol Biotechnol. 2022 Dec 22. doi: 10.1007/s12033-022-00642-6. PubMed |
| Novel suspension retroviral packaging cells generated by transposition using transposase encoding mRNA advance vector yields and enable production in bioreactors. van Heuvel Y, Schatz S, Hein M, Dogra T, Kazenmaier D, Tschorn N, Genzel Y, Stitz J. Front Bioeng Biotechnol. 2023 Apr 4;11:1076524. doi: 10.3389/fbioe.2023.1076524. eCollection 2023. PubMed |
| Novel Lipid Nanoparticles Stable and Efficient for mRNA Transfection to Antigen-Presenting Cells. Choi KC, Lee DH, Lee JW, Lee JS, Lee YK, Choi MJ, Jeong HY, Kim MW, Lee CG, Park YS. Int J Mol Sci. 2024 Jan 23;25(3):1388. doi: 10.3390/ijms25031388. PubMed |
| Innovative Cancer Immunotherapy with MAGE-A3 mRNA Cancer Vaccines. Choi K, Jeong H, Lee DH, Lee JW, Hong JE, Baek JE, Park YS. Cancers (Basel). 2024 Oct 9;16(19):3428. doi: 10.3390/cancers16193428. PubMed |
| Alternate MHC I Antigen Presentation Pathways Allow CD8+ T-cell Recognition and Killing of Cancer Cells in the Absence of beta2M or TAP. Cruz FM, Orellano LAA, Chan A, Rock KL. Cancer Immunol Res. 2025 Jan 9;13(1):98-108. doi: 10.1158/2326-6066.CIR-24-0320. PubMed |
Systematic discovery of CRISPR-boosted CAR T cell immunotherapies.
Datlinger P, Pankevich EV, Arnold CD, Pranckevicius N, Lin J, Romanovskaia D, Schaefer M, Piras F, Orts AC, Nemc A, Biesaga PN, Chan M, Neuwirth T, Artemov AV, Li W, Ladstatter S, Krausgruber T, Bock C.
Nature. 2025 Oct;646(8086):963-972. doi: 10.1038/s41586-025-09507-9. Epub 2025 Sep 24.
PubMed
Associated Plasmids |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.